“In vivo” biological standardization of the allergenic extracts Dermatophagoides pteronyssinus (DPT) and Dermatophagoides farinae (DF) in patients sensitized to them.
IgE-mediated respiratory allergic disease due to the allergen whose extract is to be standardized, DPT and DF.
Investigational medicinal product(s)
Solución para prueba con extractos alergénicos DPT 0.1 por punción cutáneaSolución para prueba con extractos alergénicos DF 0.1 por punción cutáneaSolución para prueba con extractos alergénicos DPT 10 por punción cutáneaHISTAMINE DIHYDROCHLORIDESolución para prueba con extractos alergénicos DF 10 por punción cutáneaSolución para prueba con extractos alergénicos DPT 0.01 por punción cutáneaSolución para prueba con extractos alergénicos DPT 1 por punción cutáneaSolución para prueba con extractos alergénicos DF 0.01 por punción cutáneaSolución para prueba con extractos alergénicos DF 1 por punción cutánea
Eligibility
Age group
18-64 years
Sex
Female, Male
Primary endpoint
In vivo determination of the biological activity of the allergenic extracts DPT and DF
Endpoint detail
In vitro biological standardization of DPT and DF allergenic extracts
Official registry record
This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.